Healthcare - Biotechnology - NASDAQ - US
$ 1.31
-2.24 %
$ 36.7 M
Market Cap
-0.62
P/E
INCOME STATEMENT
0
REVENUE
-67.6 M
OPERATING INCOME
-62.7 M
NET INCOME
EFFICIENCY
Earnings Waterfall
NextCure, Inc.
| Revenue | 0 |
| Cost Of Revenue | 3.68 M |
| Gross Profit | -3.68 M |
| Operating Expenses | 67.6 M |
| Operating Income | -67.6 M |
| Other Expenses | -4.91 M |
| Net Income | -62.7 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 0 | 0 | 0 | 22.4 | 6.3 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 3.7 | 4.5 | 4.3 | 46.6 K | 34.2 K | 1.7 | 0.6 |
| Gross Profit | (3.7) | (4.5) | (4.3) | 22.3 | 6.3 | (1.7) | (0.6) |
| OPERATING INCOME | |||||||
| Operating Expenses | 67.6 | 75.9 | 70.8 | 63.6 | 43.8 | 23.2 | 15.5 |
| Selling, General and Administrative Expenses | 19.7 | 21.7 | 20.6 | 17.0 | 9.6 | 3.4 | 2.6 |
| Research and Development Expenses | 47.9 | 54.2 | 50.2 | 46.6 | 34.2 | 19.8 | 13.0 |
| Operating Income | (67.6) | (75.9) | (70.8) | (41.2) | (37.5) | (23.2) | (15.5) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 0 | (5.3) | 77 K | 0.2 | 0.2 | 0 | 0 |
| Total Other Income | 4.9 | 1.2 | 1.4 | 4.6 | 3.7 | 0.4 | 80 K |
| Pre-Tax Income | (62.7) | (74.7) | (69.4) | (36.6) | (33.7) | (22.8) | (15.5) |
| NET INCOME | |||||||
| Tax Provision | 0 | (5.3) | 7.0 | (3.4) | 2.5 | 0.4 | 0 |
| Net Income | (62.7) | (69.4) | (69.4) | (33.2) | (33.7) | (22.8) | (15.5) |
| EPS | 2.25 | 2.5 | 2.51 | 1.21 | 2.15 | 2.27 | 1.54 |